Document Detail


Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia.
MedLine Citation:
PMID:  15763979     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Second malignancies are frequent complications in patients with chronic lymphocytic leukemia (CLL). Patients with this leukemia may develop large cell lymphoma (LCL) known as Richter's syndrome (RS). RS occurs in CLL patients of about 3% and may develop in a single lymph node or more often in a group of nodes. However, in some patients extranodal localization of aggressive lymphoma in RS has been observed. Besides LCL, Hodgkin's disease, prolymphocytoid leukemia, multiple myeloma and acute lymphoblastic leukemia may also occur as RS variants. The origin of lymphoid cells in RS remains tentative. However, CLL and RS originate from the same clone for some patients, whereas, in other patients cells of aggressive lymphoma do not have the features of the same clone as the CLL cells. The prognosis of RS is poor. Survival in different studies will be usually 2-5 months. The secondary development or coexistence of myeloproliferative disorders or myelodysplastic syndrome and solid tumors have also been rarely documented in CLL patients. It is of great concern that therapy may further increase the risk of a second neoplasm. However, until now, there are no clear evidence that alkylating agents or purine nucleoside analogs may be associated with an increased incidence of second malignancies in patients with CLL. In this review, epidemiology, biology, clinical characteristic and treatment approaches in RS and other secondary neoplasms in patients with CLL are discussed.
Authors:
Tadeusz Robak
Related Documents :
3477869 - Old age: a sign of poor prognosis in patients with chronic myelogenous leukemia.
12609839 - Telomerase and telomere length in multiple myeloma: correlations with disease heterogen...
2761289 - Cytogenetic studies on the adult t-cell leukemia in japan.
12377969 - Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia.
20040759 - Acute erythroid leukemia: a reassessment using criteria refined in the 2008 who classif...
7514439 - 2chlorodeoxyadenosine therapy of patients with waldenström macroglobulinemia previously...
21912719 - Maternal microchimerism in pediatric inflammatory bowel disease.
12544039 - Acute otitis media and facial nerve paralysis in adults.
82339 - Delayed cold urticaria.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Hematology (Amsterdam, Netherlands)     Volume:  9     ISSN:  1024-5332     ISO Abbreviation:  Hematology     Publication Date:    2004 Oct-Dec
Date Detail:
Created Date:  2005-03-14     Completed Date:  2005-04-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9708388     Medline TA:  Hematology     Country:  England    
Other Details:
Languages:  eng     Pagination:  387-400     Citation Subset:  IM    
Affiliation:
Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Pabianicka, Poland. robaktad@csk.am.lodz.pl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Lineage
Disease-Free Survival
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / complications*,  mortality,  therapy
Lymphoma, Large B-Cell, Diffuse / etiology*,  mortality,  therapy
Neoplasms, Second Primary / etiology*,  mortality,  therapy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular cytogenetic analysis of B-CLL patients with aggressive disease.
Next Document:  Nephrotic syndrome associated with chronic lymphocytic leukaemia.